ImmunityBio, Inc. (NASDAQ:IBRX) ranks among the 30 stocks expected to beat the market by 20 percentage points this year. With ...

A credit-card-sized chip may soon outsmart cancer.A team led by NYU Tandon School of Engineering’s Weiqiang Chen has developed a miniature device that could reshape how blood cancer treatments are ...

Biotechnology company Anixa Biosciences Inc has completed Phase 1 trials of its breast cancer vaccine Heres all you need to ...

Van Andel Institute scientists and collaborators have discovered a potential treatment target that may re-energize ...

“However, patients often don't walk in saying, ‘I'm feeling fatigued’. Instead, they typically present with symptoms like ...

“It came as a surprise that our approach works so well,” Lu said. In preclinical (non-human) studies, the vaccine completely ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

Age-related and postmenopausal breast cancer progression remains a significant challenge, with growing evidence pointing to ...

CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, ...

One of the major challenges with cancer is its ability to evade the immune system, a process known as immune evasion. This ...

Prognosis: Removal typically cures the cancer. Most SCCs are slow-growing, though this type of skin cancer is more likely to ...

Trained immunity is a form of innate immune cell memory that is being developed as a novel immunotherapeutic approach for cancer treatment.